Cosmos Holdings Inc. is a vertically integrated pharmaceutical company. The company is headquartered in Chicago, Illinois.
| Revenue (TTM) | $59.79M |
| Gross Profit (TTM) | $6.82M |
| EBITDA | $-12.62M |
| Operating Margin | -10.60% |
| Return on Equity | -63.80% |
| Return on Assets | -13.00% |
| Revenue/Share (TTM) | $2.20 |
| Book Value | $0.73 |
| Price-to-Book | 0.49 |
| Price-to-Sales (TTM) | 0.18 |
| EV/Revenue | 0.529 |
| EV/EBITDA | -1.60 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 37.90% |
| Shares Outstanding | $37.35M |
| Float | $21.43M |
| % Insiders | 36.14% |
| % Institutions | 8.09% |
Volatility is currently contracting